Gara Jalqabaatti › Myositis
Qorannoo klinikaalii Myositis Ameerikaa Keessatti hirmaatuu
Qorannoo 20 Myositis f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Durham, NCQorannoo 10
- Boston, MAQorannoo 6
- Chicago, ILQorannoo 6
- New York City, NYQorannoo 6
- Houston, TXQorannoo 5
- Miami, FLQorannoo 4
- Cedar Rapids, IAQorannoo 4
- Orange, CAQorannoo 3
- Pittsburgh, PAQorannoo 3
- Baltimore, MDQorannoo 3
- Washington, DCQorannoo 3
- Ann Arbor, MIQorannoo 3
- Jacksonville, FLQorannoo 3
- Dallas, TXQorannoo 3
- Phoenix, AZQorannoo 3
- Los Angeles, CAQorannoo 3
- Plantation, FLQorannoo 3
- Gainesville, FLQorannoo 3
- Charlotte, NCQorannoo 3
Naannoon
- AlabamaQorannoo 3
- ArizonaQorannoo 4
- CaliforniaQorannoo 11
- FloridaQorannoo 7
- GeorgiaQorannoo 3
- IllinoisQorannoo 7
- IowaQorannoo 4
- KansasQorannoo 3
- MarylandQorannoo 6
- MassachusettsQorannoo 6
- MichiganQorannoo 3
- MinnesotaQorannoo 4
- New YorkQorannoo 7
- North CarolinaQorannoo 12
- PennsylvaniaQorannoo 4
- TennesseeQorannoo 3
- TexasQorannoo 7
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Environmental Risk Factors for the Anti-synthetase Syndrome
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01276470Adult and Juvenile Myositis
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 hanga 100 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT00017914Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07103746RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 6 hanga 75 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06154252Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07823101A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05895786A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06916806A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07085104FT839 in Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07800871A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT06925542Descartes-08 in Autoantibody Myositis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07391605A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06991114A Study of AZD0120 in Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07295847A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT07115745A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 70 · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT06308978Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Elb-2026 · NCT07160205Muscle Health Measurements Using Electrical Impedance Myography
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 89 · Saalaa hunda · Haaromfame 03-Elb-2026 · NCT07502989MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 7 fi ol · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT07374107Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 16-Ama-2026 · NCT06479863Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.